RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pfizer Inc.

A collection of news and information related to Pfizer Inc. published by this site and its partners.

Top Pfizer Inc. Articles see all

Displaying items 1-5
  • Pfizer stops China vaccine sales as import license expires

    Pfizer has stopped selling its Prevnar 7 pneumonia vaccine in China after its import license expired, but the U.S. drugmaker still intends to launch the world's most widely used vaccine, Prevnar 13, in that market.
  • Retailers target singles with wine tastings, apartment furnishings

    NEW YORK — Whole Foods is holding wine tastings. Ikea is pitching apartment furniture to divorced dads. Applebee's turns into a nightclub after dinner. These companies are all targeting an increasingly coveted demographic: single Americans. More...

    Pill look different? Shape and color changes may prompt lapses

    Pill look different? Shape and color changes may prompt lapses
    In a decade, Americans have saved an estimated $1.2 trillion by taking generic drugs instead of the high-priced originals. But the booming market in copycat prescription pharmaceuticals - coupled with insurance companies' efforts to keep healthcare...

    FDA says new cholesterol drugs may not need outcome studies

    FDA says new cholesterol drugs may not need outcome studies
    Members of an experimental class of cholesterol-lowering drugs could get U.S. regulatory approval based on their ability to lower "bad" cholesterol, and may not need to show that they reduce the risk of heart attack and stroke, the Food and Drug...

    FDA bars medications made by Indian generics giant Ranbaxy

    FDA bars medications made by Indian generics giant Ranbaxy
    The Food & Drug Administration on Monday barred the import of any medications made at the premier manufacturing plant of one of the world's largest makers of generic medications, Ranbaxy Laboratories Ltd. The FDA cited Ranbaxy's failure to respond...